Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Berberine for regression of hepatitis B-related liver fibrosis
ChiCTR1900023426Phase 4Not yet recruiting
- Sponsor
- Department of Gastroenterology, The Third Affiliated Hospital of Sun Yat-sen University
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of berberine in hepatic fibrosis and Chronic Hepatitis B (CHB) (2 arms), sponsored by Department of Gastroenterology, The Third Affiliated Hospital of Sun Yat-sen University. Primary endpoints: Liver stiffness, Liver tissue inflammation assessment and 1 more. Planned start Jun 2019; status: not yet recruiting.
02
Drugs
berberine
03
Conditions
hepatic fibrosisChronic Hepatitis B (CHB)
Beyond the preview
Go deeper on ChiCTR1900023426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900023426.